Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 39 Records) |
| Query Trace: Disease Progression and PTEN[original query] |
|---|
| A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study). Cancer 2016 Sep . Makker Vicky, Recio Fernando O, Ma Ling, Matulonis Ursula A, Lauchle Jennifer O, Parmar Hema, Gilbert Houston N, Ware Joseph A, Zhu Rui, Lu Shan, Huw Ling-Yuh, Wang Yulei, Koeppen Hartmut, Spoerke Jill M, Lackner Mark R, Aghajanian Carol |
| Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients. BMC cancer 2016 Nov 16 (1): 864. Ko Ryo, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Wakuda Kazushige, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Isaka Mitsuhiro, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyuki, Takahashi Kazuhisa, Takahashi Toshia |
| Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. Oncotarget 2017 Nov 8 (55): 93464-93475. Gleeson Ferga C, Voss Jesse S, Kipp Benjamin R, Kerr Sarah E, Van Arnam John S, Mills John R, Marcou Cherisse A, Schneider Amber R, Tu Zheng Jin, Henry Michael R, Levy Michael |
| Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC). Gynecologic oncology 2017 Jan . Spreafico A, Oza A M, Clarke B A, Mackay H J, Shaw P, Butler M, Dhani N C, Lheureux S, Wilson M K, Welch S, Zhang T, Yu C, Stockley T, Siu L L, Kamel-Reid S, Bedard P |
| Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas. Gynecologic oncology 2018 9 151 (2): 243-249. Liu Yihua, Weber Zachary, San Lucas F Anthony, Deshpande Aditya, Jakubek Yasminka A, Sulaiman Raed, Fagerness Mary, Flier Natasha, Sulaiman Joseph, Davis Christel M, Fowler Jerry, Starks David, Rojas-Espaillat Luis, Lazar Alexander J, Davies Gareth E, Ehli Erik A, Scheet Pa |
| SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Aug . Boysen Gunther, Rodrigues Daniel N, Rescigno Pasquale, Seed George, Dolling David, Riisnaes Ruth, Crespo Mateus, Zafeiriou Zafeiris, Sumanasuriya Semini, Bianchini Diletta, Hunt Joanne, Moloney Deirdre, Perez-Lopez Raquel, Tunariu Nina, Miranda Susana, Figueiredo Inês, Ferreira Ana, Christova Rossitza, Gil Veronica, Aziz Sara, Bertan Claudia, de Oliveira Flavia M, Atkin Mark, Clarke Matthew, Goodall Jane, Sharp Adam, MacDonald Theresa, Rubin Mark A, Yuan Wei, Barbieri Christopher E, Carreira Suzanne, Mateo Joaquin, de Bono Johann |
| The genetic landscape of ganglioglioma. Acta neuropathologica communications 2018 Jun 6 (1): 47. Pekmezci Melike, Villanueva-Meyer Javier E, Goode Benjamin, Van Ziffle Jessica, Onodera Courtney, Grenert James P, Bastian Boris C, Chamyan Gabriel, Maher Ossama M, Khatib Ziad, Kleinschmidt-DeMasters Bette K, Samuel David, Mueller Sabine, Banerjee Anuradha, Clarke Jennifer L, Cooney Tabitha, Torkildson Joseph, Gupta Nalin, Theodosopoulos Philip, Chang Edward F, Berger Mitchel, Bollen Andrew W, Perry Arie, Tihan Tarik, Solomon David |
| Clinical outcomes associated with pathogenic genomic instability mutations in prostate cancer: a retrospective analysis of US pharmacy and medical claims data. Journal of medical economics 2019 7 22 (10): 1080-1087. Liu Jinan, Near Aimee, Chiarappa Joseph A, Wada Keiko, Tse Jenny, Burudpakdee Chakkarin, Behl Ajay, Ranganath Radhika, Antonarakis Emmanuel |
| Identification of key pathways and genes in PTEN mutation prostate cancer by bioinformatics analysis. BMC medical genetics 2019 12 20 (1): 191. Sun Jian, Li Shugen, Wang Fei, Fan Caibin, Wang Jianqi |
| Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors. Nature cancer 2020 9 1 (4): 382-393. Razavi Pedram, Dickler Maura N, Shah Payal D, Toy Weiyi, Brown David N, Won Helen H, Li Bob T, Shen Ronglai, Vasan Neil, Modi Shanu, Jhaveri Komal, Caravella Betty Ann, Patil Sujata, Selenica Pier, Zamora Stephen, Cowan Aimee M, Comen Elizabeth, Singh Andy, Covey Anne, Berger Michael F, Hudis Clifford A, Norton Larry, Nagy Rebecca J, Odegaard Justin I, Lanman Richard B, Solit David B, Robson Mark E, Lacouture Mario E, Brogi Edi, Reis-Filho Jorge S, Moynahan Mary Ellen, Scaltriti Maurizio, Chandarlapaty Sar |
| Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients. Cancers 2020 8 12 (9): . Hilke Franz J, Sinnberg Tobias, Gschwind Axel, Niessner Heike, Demidov German, Amaral Teresa, Ossowski Stephan, Bonzheim Irina, Röcken Martin, Riess Olaf, Garbe Claus, Schroeder Christopher, Forschner Andr |
| Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study. BMC medicine 2021 9 19 (1): 206. Zhang Yongchang, Zhang Xiangyu, Zhang Ruiguang, Xu Qinqin, Yang Haiyan, Lizaso Analyn, Xu Chunwei, Liu Jun, Wang Wenxian, Ou Sai-Hong Ignatius, Zhang Jiexia, Song Zhengbo, Yang No |
| PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors. Clinical lung cancer 2021 Feb . Ferrara Miriam Grazia, Martini Maurizio, D'Argento Ettore, Forcella Chiara, Vita Emanuele, Di Noia Vincenzo, Sperduti Isabella, Bilotta Mirna, Ribelli Marta, Damiano Paola, Cannella Antonella, Stefani Alessio, Pilotto Sara, Carbone Carmine, Piro Geny, Milella Michele, Tortora Giampaolo, Bria Emil |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I. JCO precision oncology 2022 2 6 e2100424. Krop Ian E, Jegede Opeyemi A, Grilley-Olson Juneko E, Lauring Josh D, Mitchell Edith P, Zwiebel James A, Gray Robert J, Wang Victoria, McShane Lisa M, Rubinstein Larry V, Patton David, Williams P Mickey, Hamilton Stanley R, Kono Scott A, Ford James M, Garcia Agustin A, Sui Xingwei D, Siegel Robert D, Slomovitz Brian M, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
| Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 2 35 (8): 1066-1074. Stradella Agostina, Gargallo Pablo, Cejuela Mónica, Petit Anna, Bosch-Schips Jan, Carbonell Paula, Recalde Sabela, Vethencourt Andrea, Fernandez-Ortega Adela, Falo Catalina, Gil-Gil Miguel, Vázquez Silvia, Obadia Verónica, Villanueva-Vázquez Rafael, Soler-Monsó Teresa, Calabria Inés, Pernas Son |
| Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study. Therapeutic advances in medical oncology 2022 11 14 17588359221133546. Yu Yongfeng, Ren Yongxin, Fang Jian, Cao Lejie, Liang Zongan, Guo Qisen, Han Sen, Ji Zimei, Wang Ye, Sun Yulan, Chen Yuan, Li Xingya, Xu Hua, Zhou Jianying, Jiang Liyan, Cheng Ying, Han Zhigang, Shi Jianhua, Chen Gongyan, Ma Rui, Fan Yun, Sun Sanyuan, Jiao Longxian, Jia Xiaoyun, Wang Linfang, Lu Puhan, Xu Qian, Luo Xian, Su Weiguo, Lu Sh |
| Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease Progression. Cancers 2023 8 15 (15): . Sungun Bang, Dongju Won, Saeam Shin, Kang Su Cho, Jae Won Park, Jongsoo Lee, Young Deuk Choi, Suwan Kang, Seung-Tae Lee, Jong Rak Choi, Hyunho H |
| Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer. Genome medicine 2023 7 15 (1): 55. Yeon Hee Park, Seock-Ah Im, Kyunghee Park, Ji Wen, Kyung-Hun Lee, Yoon-La Choi, Won-Chul Lee, Ahrum Min, Vinicius Bonato, Seri Park, Sripad Ram, Dae-Won Lee, Ji-Yeon Kim, Su Kyeong Lee, Won-Woo Lee, Jisook Lee, Miso Kim, Hyun Seon Kim, Scott L Weinrich, Han Suk Ryu, Tae Yong Kim, Stephen Dann, Yu-Jin Kim, Diane R Fernandez, Jiwon Koh, Shuoguo Wang, Song Yi Park, Shibing Deng, Eric Powell, Rupesh Kanchi Ravi, Jadwiga Bienkowska, Paul A Rejto, Woong-Yang Park, Zhengyan K |
| Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 2023 4 7 e2200421. Wisinski Kari B, Flamand Yael, Wilson Melissa A, Luke Jason J, Tawbi Hussein A, Hong Fangxin, Mitchell Edith P, Zwiebel James A, Chen Helen, Gray Robert J, Li Shuli, McShane Lisa M, Rubinstein Lawrence V, Patton David, Williams P Mickey, Hamilton Stanley R, Behrens Robert J, Pennington Kathryn P, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
| Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. European journal of cancer (Oxford, England : 1990) 2023 3 185 105-118. Lozano Rebeca, Castro Elena, Lopez-Campos Fernando, Thorne Heather, Ramirez-Backhaus Miguel, Aragon Isabel M, Cendón-Florez Ylenia, Gutierrez-Pecharroman Ana, Salles Daniela C, Romero-Laorden Nuria, Lorente David, González-Peramato Pilar, Calatrava Ana, Alonso Concepción, Anido Urbano, Arévalo-Lobera Sara, Balmaña Judith, Chirivella Isabel, Juan-Fita María José, Llort Gemma, Y Cajal Teresa Ramón, Almagro Elena, Alameda Daniel, López-Casas Pedro P, Herrera Bernardo, Mateo Joaquin, Pritchard Colin C, Antonarakis Emmanuel S, Lotan Tamara L, Rubio-Briones José, Sandhu Shahneen, Olmos Dav |
| Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 100150. Dogan Snjezana, Xu Bin, Rana Satshil, Chen Hui, Ghossein Ronald A, Berger Michael F, Ho Alan L, Katabi No |
| Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
| Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 10 . Paul Stockhammer, Michael Grant, Anna Wurtz, Giorgia Foggetti, F Expósito, Jianlei Gu, Hongyu Zhao, Jungmin Choi, Sangyun Chung, Fangyong Li, Zenta Walther, Julia Dietz, Emily Duffield, Scott Gettinger, Katerina Politi, Sarah B Goldbe |
| Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma. Cancers 2023 1 15 (1): . Zhou Maggie, Bui Nam, Rathore Richa, Sudhaman Sumedha, George Giby V, Malashevich Allyson K, Malhotra Meenakshi, Liu Minetta C, Aleshin Alexey, Ganjoo Kristen |
| Ipatasertib plus Paclitaxel for patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 7 . Rebecca A Dent, Sung-Bae Kim, Mafalda Oliveira, Carlos Barrios, Joyce O'Shaughnessy, Steven J Isakoff, Shigehira Saji, Ruffo Freitas-Junior, Manuel Philco, Igor Bondarenko, Qinshu Lian, Denise Bradley, Heather Hinton, Matthew J Wongchenko, Sarah-Jayne Reilly, Nicholas Turn |
| Racial Disparities in Glioblastoma Genomic Alterations: A Comprehensive Analysis of a Multi-institution Cohort of 2,390 patients. World neurosurgery 2024 6 . Danny John, Mohammed Alshalalfa, Timoteo Almeida, Anna Murray, Joao Marques, Gregory Azzam, Eric A Mellon, Carolina G Benjamin, Ricardo J Komotar, Michael Ivan, Brandon Mahal, Benjamin J Ri |
| GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
| Clinical impact of PTEN rs701848 as a predictive marker for breast cancer. Clinical biochemistry 2025 1 110872. Basma El-Sayed Fotouh, Mai Abd El-Meguid, Ghada Maher Salum, Ghada Nabil El Naggar, Ahmed F El-Sayed, Reham Mohammed Dawo |
- Page last reviewed:Feb 1, 2024
- Content source: